Predicting mortality in chronic obstructive pulmonary disease: Chasing the "holy grail"

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 12, 2006, Pages 1298-1299

  Celli, Bartolome R ^a,b  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

AIRWAY OBSTRUCTION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EDITORIAL; MORTALITY; MUSCLE WEAKNESS; PRIORITY JOURNAL; SURVIVAL; UNITED STATES;

AGE FACTORS; AIRWAY OBSTRUCTION; BODY MASS INDEX; DYSPNEA; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; FORECASTING; HUMANS; LUNG COMPLIANCE; OXYGEN INHALATION THERAPY; PHYSICAL ENDURANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SURVIVAL RATE;

EID: 33745152655     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.2602003     Document Type: Editorial

References (16)

1. Mannino D. M. Epidemiology and global impact of chronic obstructive pulmonary disease. Semin Respir Crit Care Med 2005;26:204-210.
2. Fletcher CM, Tinker CM, Peto R, Speizer FE. The natural history of chronic bronchitis and emphysema. Oxford, UK: Oxford University Press; 1976.
3. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-1797.
4. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-minute walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004;1:28-33.
5. Celli BR, MacNee W. Standards for the diagnosis and treatment of COPD. Eur Respir J 2004;23:932-946.
6. Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, DeCamp MM, Benditt J, Sciurba F, Make B, et al., for the NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173:1326-1334.
7. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012.
8. Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR. C-reactive protein in patients with COPD, control smokers, and nonsmokers. Thorax 2006;61:23-28.
9. Koechlin C, Maltais F, Saey D, Michaud A, LeBlanc P, Hayot M, Preafaut C. Hypoxemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax 2005;60:834-841.
10. Agusti AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, Batle S, Busquets X. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:485-489.
11. Montes de Oca M, Torres SH, De Sanctis J, Mata A, Hernández N, Tálamo C. Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J 2005;26:1-8.
12. Mercken EM, Hageman GJ, Schols AM, Akkermans MA, Bast A, Wouters EF. Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:994-1001.
13. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005;26:630-636.
14. Sin DD, Lacy P, York E, Man SFP. Effects of fluticasone on systematic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:760-765.
15. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
16. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:591-597.